11 Hrs_1777292798912_197359786.jpg&w=48&q=75)
Source:
عكس السير
Deutsche Welle: Complete overview of weight loss pills in Europe
The European Commission has approved the use of Wegovy in tablet form for weight management. It is the first oral treatment containing the active ingredient semaglutide, similar to what is found in the injectable form. The oral medication helps reduce appetite and increase feelings of fullness and is administered daily on an empty stomach, following precise instructions to ensure effective absorption. Studies have shown that the tablets can lead to approximately a 14% weight reduction over 64 weeks, while the injectable form can achieve about a 19% weight loss after 72 weeks. The side effects of both methods are similar and include nausea and diarrhea, but the advantages of the tablets relate to their ease of use and the preference many have for oral over injectable treatment, with use requiring medical supervision.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)